These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
556 related articles for article (PubMed ID: 22612696)
21. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review. Phukan K; Nandy M; Sharma RB; Sharma HK Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366 [TBL] [Abstract][Full Text] [Related]
22. The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs. Wang Y; Pi C; Feng X; Hou Y; Zhao L; Wei Y Int J Nanomedicine; 2020; 15():6295-6310. PubMed ID: 32943863 [TBL] [Abstract][Full Text] [Related]
23. Drug targeting to cancer by nanoparticles surface functionalized with special biomolecules. Holgado MA; Martin-Banderas L; Alvarez-Fuentes J; Fernandez-Arevalo M; Arias JL Curr Med Chem; 2012; 19(19):3188-95. PubMed ID: 22612702 [TBL] [Abstract][Full Text] [Related]
25. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725 [TBL] [Abstract][Full Text] [Related]
26. Colloidal polymeric nanoparticles and brain drug delivery. Khalil NM; Mainardes RM Curr Drug Deliv; 2009 Jul; 6(3):261-73. PubMed ID: 19604140 [TBL] [Abstract][Full Text] [Related]
27. Polymeric micelles for oral drug administration enabling locoregional and systemic treatments. Simões SM; Figueiras AR; Veiga F; Concheiro A; Alvarez-Lorenzo C Expert Opin Drug Deliv; 2015 Feb; 12(2):297-318. PubMed ID: 25227130 [TBL] [Abstract][Full Text] [Related]
28. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers. Moritz M; Geszke-Moritz M Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624 [TBL] [Abstract][Full Text] [Related]
29. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art. Karim R; Palazzo C; Evrard B; Piel G J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752 [TBL] [Abstract][Full Text] [Related]
30. Disposition of nanoparticle-based delivery system via inner ear administration. Chen G; Zhang X; Yang F; Mu L Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174 [TBL] [Abstract][Full Text] [Related]
32. Effects of borneol on the pharmacokinetics of 9-nitrocamptothecin encapsulated in PLGA nanoparticles with different size via oral administration. Ru G; Han L; Qing J; Sheng J; Li R; Qiu M; Wang J Drug Deliv; 2016 Nov; 23(9):3417-3423. PubMed ID: 27174642 [TBL] [Abstract][Full Text] [Related]
33. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice. Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790 [TBL] [Abstract][Full Text] [Related]
34. Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration. Kadakia E; Bottino D; Amiji M Pharm Res; 2019 Mar; 36(5):75. PubMed ID: 30923914 [TBL] [Abstract][Full Text] [Related]
35. Transport of drugs across the blood-brain barrier by nanoparticles. Wohlfart S; Gelperina S; Kreuter J J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624 [TBL] [Abstract][Full Text] [Related]
36. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Fleige E; Quadir MA; Haag R Adv Drug Deliv Rev; 2012 Jun; 64(9):866-84. PubMed ID: 22349241 [TBL] [Abstract][Full Text] [Related]
37. Recent advances in delivery through the blood-brain barrier. Larsen JM; Martin DR; Byrne ME Curr Top Med Chem; 2014; 14(9):1148-60. PubMed ID: 24678707 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers. Florek J; Caillard R; Kleitz F Nanoscale; 2017 Oct; 9(40):15252-15277. PubMed ID: 28984885 [TBL] [Abstract][Full Text] [Related]
39. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier. Tam VH; Sosa C; Liu R; Yao N; Priestley RD Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885 [TBL] [Abstract][Full Text] [Related]
40. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs. Wang XQ; Zhang Q Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]